273 related articles for article (PubMed ID: 37272017)
1. Targeted Knockdown of Macrophage Migration Inhibitory Factor Enhances UVB Irradiation-Induced Apoptosis Via Increasing ROS Generation in Oral Squamous Cell Carcinoma.
Chen T; Chen Q; Li F; Zeng M; Wang B; Huang S; Chen S; Tao Z
Technol Cancer Res Treat; 2023; 22():15330338231163436. PubMed ID: 37272017
[No Abstract] [Full Text] [Related]
2. Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
Zeng J; Quan J; Xia X
Mol Med Rep; 2016 Jan; 13(1):174-80. PubMed ID: 26549761
[TBL] [Abstract][Full Text] [Related]
3. Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9
Duan Y; Huang X; Qiao B; Ma R; Li J
Anticancer Agents Med Chem; 2022 Aug; 22(15):2799-2806. PubMed ID: 35331101
[TBL] [Abstract][Full Text] [Related]
4. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
Dawei H; Honggang D; Qian W
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Wang SS; Zheng M; Pang X; Zhang M; Yu XH; Wu JB; Gao XL; Wu JS; Yang X; Tang YJ; Tang YL; Liang XH
Mol Carcinog; 2019 Oct; 58(10):1809-1821. PubMed ID: 31219646
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of alantolactone on oral squamous cell carcinoma cells.
Zhang Y; Yang B; Tu C; Ping Y; Chen S; Wu T; Zhao Z; Mao Y; Yang Z; Cao Z; Li J; Huang K; Ding X; Wu G; Zou P; Deng Z; Sun X
J Transl Med; 2023 May; 21(1):328. PubMed ID: 37198593
[TBL] [Abstract][Full Text] [Related]
9. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
10. miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling.
Ma J; Na S; Wang P; Li J; He S; Liu F
Cancer Biother Radiopharm; 2024 Mar; 39(2):144-152. PubMed ID: 35549438
[No Abstract] [Full Text] [Related]
11. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
Tong S; Wang X; Guo X; Lu Z
J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin suppressed tumour growth and induced vascular normalisation in oral squamous cell carcinoma via inhibition of macrophage migration inhibitory factor.
Yu XH; Wu JB; Fan HY; Dai L; Xian HC; Chen BJ; Liao P; Huang MC; Pang X; Zhang M; Liang XH; Tang YL
Oral Dis; 2024 Mar; 30(2):363-375. PubMed ID: 36321394
[TBL] [Abstract][Full Text] [Related]
14. [Effect of circular RNA hsa_circ_0008898 on oral squamous cell carcinoma and its mechanism].
Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):578-585. PubMed ID: 32842350
[No Abstract] [Full Text] [Related]
15. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
[TBL] [Abstract][Full Text] [Related]
16. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
[TBL] [Abstract][Full Text] [Related]
17. Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway.
Zhao Q; Cheng X; Yu W; Bi Y; Guo J; Ma Q; Gong Y; He L; Yu X
Phytomedicine; 2021 Nov; 92():153723. PubMed ID: 34482221
[TBL] [Abstract][Full Text] [Related]
18. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
[No Abstract] [Full Text] [Related]
19. Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells.
Zhang X; Huang Z; Hu Y; Liu L
J Oral Pathol Med; 2016 Nov; 45(10):740-745. PubMed ID: 27561828
[TBL] [Abstract][Full Text] [Related]
20. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
Hou Z; Wu C; Tang J; Liu S; Li L
Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
